Corneal endotheliitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:137602H16.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Corneal endotheliitis is a rare inflammatory condition of the eye that specifically targets the corneal endothelium — the innermost single-cell layer of the cornea responsible for maintaining corneal clarity by regulating fluid balance. The disease is characterized by corneal edema (swelling), keratic precipitates (inflammatory deposits on the inner corneal surface), and mild anterior chamber inflammation. Patients typically present with blurred vision, eye redness, and discomfort, often unilaterally, though bilateral involvement can occur. The condition is frequently associated with viral infections, particularly herpes simplex virus (HSV), varicella-zoster virus (VZV), and cytomegalovirus (CMV), which are believed to trigger an immune-mediated inflammatory response against the endothelial cells. Three clinical patterns have been described: disciform, diffuse, and linear endotheliitis, each with distinct distributions of keratic precipitates and corneal edema. Disciform endotheliitis presents with a central disc-shaped area of edema, linear endotheliitis shows a progressive line of keratic precipitates, and diffuse endotheliitis involves widespread endothelial inflammation. If left untreated, chronic or recurrent episodes can lead to permanent endothelial cell loss and irreversible corneal decompensation requiring corneal transplantation. Treatment typically involves a combination of topical corticosteroids to control inflammation and antiviral therapy (such as acyclovir, valacyclovir, or ganciclovir, depending on the suspected viral etiology) to address the underlying infectious trigger. In CMV-associated cases, topical ganciclovir has shown particular efficacy. Early diagnosis and prompt treatment are essential to preserve endothelial cell density and maintain corneal transparency. Recurrences are common, and some patients may require long-term low-dose antiviral prophylaxis to prevent further episodes of inflammation and progressive endothelial cell loss.

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Corneal endotheliitis.

View clinical trials →

No actively recruiting trials found for Corneal endotheliitis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Corneal endotheliitis community →

No specialists are currently listed for Corneal endotheliitis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Corneal endotheliitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Corneal endotheliitisForum →

No community posts yet. Be the first to share your experience with Corneal endotheliitis.

Start the conversation →

Latest news about Corneal endotheliitis

No recent news articles for Corneal endotheliitis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Corneal endotheliitis

What is Corneal endotheliitis?

Corneal endotheliitis is a rare inflammatory condition of the eye that specifically targets the corneal endothelium — the innermost single-cell layer of the cornea responsible for maintaining corneal clarity by regulating fluid balance. The disease is characterized by corneal edema (swelling), keratic precipitates (inflammatory deposits on the inner corneal surface), and mild anterior chamber inflammation. Patients typically present with blurred vision, eye redness, and discomfort, often unilaterally, though bilateral involvement can occur. The condition is frequently associated with viral inf

At what age does Corneal endotheliitis typically begin?

Typical onset of Corneal endotheliitis is adult. Age of onset can vary across affected individuals.